Vimarsana
Biggest News Aggregation in the World

Page 5 - Beckley Psytech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Beckley Psytech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Beckley Psytech Today - Breaking & Trending Today

Baystreet.ca - Breaking: The US FDA Just Granted Priority Review of an MDMA Treatment for PTSD - Vimarsana News

Baystreet.ca - Breaking: The US FDA Just Granted Priority Review of an MDMA Treatment for PTSD

At the moment, about 14 million people live with PTSD just in the U.S. Unfortunately, despite extensive clinical research, PTSD is still a significant unmet medical need. However, that may soon change with the US FDA’s acceptance of a New Drug ...

Trial of new psychedelic drug seeks patients with Treatment - Vimarsana News

Trial of new psychedelic drug seeks patients with Treatment

London, Feb. 07, 2024 (GLOBE NEWSWIRE) -- An international clinical trial which is investigating a novel synthetic formulation of the psychedelic...

Numinus Wellness Inc. Announces First Quarter Fiscal 2024 Results - Vimarsana News

Numinus Wellness Inc. Announces First Quarter Fiscal 2024 Results

Q1 Fiscal 2024 Highlights Gross profit of $2.1 million, an 18.8% increase over Q4 2023 Revenue of $5.9 million, a 3.0% decline over Q4 2023 Reduced operating...

Numinus Wellness Inc. Announces First Quarter Fiscal 2024 Results - Vimarsana News

Numinus Wellness Inc. Announces First Quarter Fiscal 2024 Results

Q1 Fiscal 2024 Highlights Gross profit of $2.1 million, an 18.8% increase over Q4 2023Revenue of $5.9 million, a 3.0% decline over Q4 2023Reduced operating expenditures of 19.9% over Q4 2023Cash...

30 Psychedelics Executives, Scientists & Influencers To Watch In 2024 And Beyond - Enveric Biosciences (NASDAQ:ENVB), Cybin (AMEX:CYBN) - Vimarsana News

30 Psychedelics Executives, Scientists & Influencers To Watch In 2024 And Beyond - Enveric Biosciences (NASDAQ:ENVB), Cybin (AMEX:CYBN)

The emerging psychedelics industry is expanding rapidly across the globe. With research demonstrating promising therapeutic potential for substances like psilocybin and MDMA to treat mental health conditions, this sector has attracted growing attention and investment.